US fraud inquiry targets Fresenius
Probe comes 5 years after dialysis chain settled Medicare case
Fresenius Medical Care AG , a global dialysis chain with North American headquarters in Lexington, is under the microscope again just five years after it reached a $486 million Medicare fraud settlement with the government. (Full article: 494 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
